Deseret Mutual Benefit Administrators’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$89.5K Sell
989
-74
-7% -$6.2K 0.03% 314
2026
Q1
$85.1K Buy
1,063
+558
+110% +$46K 0.03% 322
2025
Q4
$43.1K Hold
505
0.02% 342
2025
Q3
$39.3K Buy
505
+17
+3% +$1.33K 0.02% 346
2025
Q2
$38.2K Hold
488
0.02% 340
2025
Q1
$35.4K Hold
488
0.02% 344
2024
Q4
$36.1K Buy
488
+130
+36% +$9.1K 0.02% 341
2024
Q3
$23.6K Hold
358
0.01% 409
2024
Q2
$33.1K Buy
358
+100
+39% +$8.86K 0.02% 352
2024
Q1
$24.7K Hold
258
0.01% 409
2023
Q4
$19.7K Sell
258
-8
-3% -$557 0.01% 428
2023
Q3
$18.4K Hold
266
0.01% 450
2023
Q2
$25.1K Buy
266
+24
+10% +$2.09K 0.01% 422
2023
Q1
$20K Hold
242
0.01% 438
2022
Q4
$18.1K Sell
242
-207
-46% -$16K 0.01% 448
2022
Q3
$37K Sell
449
-84
-16% -$8.08K 0.01% 434
2022
Q2
$51K Hold
533
0.01% 421
2022
Q1
$63K Sell
533
-84
-14% -$9.42K 0.01% 424
2021
Q4
$80K Buy
617
+219
+55% +$25.5K 0.01% 406
2021
Q3
$45K Hold
398
0.01% 468
2021
Q2
$41K Buy
+398
New +$37.5K 0.01% 472

Other funds holding EW

Deseret Mutual Benefit Administrators's EW Position: Q2 2026 in Review

Deseret Mutual Benefit Administrators reduced its Edwards Lifesciences (EW) stake by 7% in Q2 2026, selling an estimated $6.2K and leaving 989 shares worth $89.5K. The position accounts for 0.03% of the portfolio, ranked #314.

Deseret Mutual Benefit Administrators first reported a position in EW in Q2 2021 and has held it in 21 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Deseret Mutual Benefit Administrators held 989 shares of Edwards Lifesciences worth $89.5K as of Q2 2026.
  • Deseret Mutual Benefit Administrators sold 74 Edwards Lifesciences shares in Q2 2026, an estimated $6.2K.
  • Edwards Lifesciences made up 0.03% of Deseret Mutual Benefit Administrators's portfolio in Q2 2026, its #314 holding.
  • Deseret Mutual Benefit Administrators first reported a position in Edwards Lifesciences in Q2 2021 and has held it in 21 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Deseret Mutual Benefit Administrators's 13F filing for Q2 2026, filed 14 Aug 2026.